Media Mentions

Anna Terteryan Featured in Law360 Pulse on Joining Benesch’s San Francisco Litigation Team

October 28, 2025

Anna Terteryan, a partner in Benesch’s Litigation Practice Group, was featured in Law360 Pulse on her decision to join the firm after more than a decade practicing at Kirkland & Ellis LLP. 

“Benesch’s growth and trajectory over the past several years is incredibly impressive,” said Anna. “That’s a credit to its people. From leadership to support staff, we act as one team open to new ideas and committed to a common purpose: providing exceptional legal service and expanding our reach to serve more clients. I’m energized by this opportunity to help build out our San Francisco presence and get the word out about all that this extraordinary firm has to offer.”

Anna focuses her practice on a wide range of complex and high-stakes litigation matters in areas such as securities and other financial litigation, multidistrict and class action litigation, contract disputes, unfair competition cases, trade secret misappropriation, contested bankruptcy proceedings and appellate matters.

Read the full article.

Latest News

Media Mentions 5.29.26

Bloomberg Law Quotes Benesch Partner Margo Wolf O’Donnell on USDA Line Speed Proposal and Worker Safety Risks

Margo Wolf O’Donnell, Co-Chair of Benesch’s Labor & Employment Practice Group, was quoted in Bloomberg Law discussing how the USDA’s proposal to increase meat processing line speeds is raising concerns that faster production could worsen worker safety risks, highlighting tensions between regulatory priorities, industry demands and potential legal challenges.

Media Mentions 5.26.26

Benesch Partner Mark Silberman Quoted in Crain’s Chicago Business on AI-Driven Medicaid Audits and Provider Compliance Risks

Mark Silberman, Vice Chair of Benesch’s Healthcare Practice Group, was quoted in Crain’s Chicago Business article, “The feds’ AI fraud hunt alarms Medicaid providers.” The article examines a new federal effort to use AI to analyze Medicaid audits for fraud, as well as concerns that it could penalize healthcare providers for routine billing errors and create broader financial and operational risks.